We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Immunex Corp /De/ Sample Contracts

Standard Contracts

among
Purchase Agreement • November 13th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
Exhibit 10.2 IMMUNEX CORPORATION FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreement • August 11th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
Common Stock (par value $0.01 per share)
Underwriting Agreement • November 15th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
AGREEMENT ---------
Supply Agreement • May 7th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
BY AND AMONG AMGEN INC.,
Merger Agreement • December 17th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 1 TO PURCHASE AGREEMENT
Purchase Agreement • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
RECITALS
Employment Agreement • March 18th, 1996 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.3 Secured Promissory Note -----------------------
Secured Promissory Note • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
LEASE between IMMUNEX REAL ESTATE TRUST 2001, as Lessor, and IMMUNEX CORPORATION, as Lessee
Lease • March 5th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 2 to AMENDED AND RESTATED GOVERNANCE AGREEMENT
Governance Agreement • August 10th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
ARTICLE II VOTING AGREEMENT AND IRREVOCABLE PROXY
Shareholder Voting Agreement • December 17th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Delaware
FOURTH AMENDMENT TO REAL ESTATE PURCHASE AND SALE AGREEMENT
Real Estate Purchase and Sale Agreement • March 23rd, 1998 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT...
Note Purchase Agreement • May 28th, 1999 • Immunex Corp /De/ • Biological products, (no disgnostic substances)

THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT (A) IT IS A "QUALIFIED INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) OR (B) IT IS AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS DEFINED IN RULE 501(A)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT) ("INSTITUTIONAL ACCREDITED INVESTOR"); (2) AGREES THAT IT WILL NOT, PRIOR TO EXPIRATION OF THE HOLDING PERIOD APPLICABLE TO SALES OF THE NOTE EVIDENCED HEREBY UNDER RULE 144 UNDER THE SECURITIES ACT (OR ANY SUCCESSOR PROVISION), RESELL OR OTHERWISE TRANSFER THE NOTE EVIDENCED HEREBY OR THE COMMON STOCK ISSUABLE UPON CONVERSION OF SUCH NOTE EXCEPT (A) TO IMMUNEX CORPORATION OR ANY SUBSIDIARY THE

MARTIN SELIG REAL ESTATE 1000 SECOND AVENUE OFFICE LEASE
Office Lease • March 23rd, 1998 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.3 AGENCY AGREEMENT
Agency Agreement • March 5th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.1 PRODUCT RIGHTS AGREEMENT
Product Rights Agreement • July 1st, 1998 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New Jersey